Successful Handling of Disseminated BCG Disease in a Child with Severe Combined Immunodeficiency
In high-burden countries, Mycobacterium bovis Bacillus Calmette-Guérin (BCG) vaccine is administered in newborn to prevent severe Mycobacterium tuberculosis infection. Because life-threatening disseminated BCG disease may occur in children with primary immunodeficiency, vaccination strategy against...
Saved in:
Main Authors: | Sílvia Bacalhau, Cristina Freitas, Rosalina Valente, Deolinda Barata, Conceição Neves, Katrin Schäfer, Annelie Lubatschofski, Ansgar Schulz, João Farela Neves |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2011/527569 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In-Hospital Mortality of Disseminated Tuberculosis in Patients Infected with the Human Immunodeficiency Virus
by: Rodrigo Pires dos Santos, et al.
Published: (2011-01-01) -
Renal Evaluation in Common Variable Immunodeficiency
by: Giovany Gomes Capistrano, et al.
Published: (2018-01-01) -
Neonatal BCG vaccination and child survival in TB-exposed and TB-unexposed children: a prospective cohort study
by: Peter Aaby, et al.
Published: (2020-02-01) -
Bacillus Calmette-Guerin (BCG) infections following intravesical BCG immunotherapy: a systematic review protocol
by: Roberta Monardo, et al.
Published: (2025-01-01) -
Is the BCG Vaccine Safe for Undernourished Individuals?
by: Larissa Lumi Watanabe Ishikawa, et al.
Published: (2012-01-01)